Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by O Brien Greene & Co. Inc

O Brien Greene & Co. Inc lessened its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 6.8% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,105 shares of the biotechnology company’s stock after selling 300 shares during the period. O Brien Greene & Co. Inc’s holdings in Axon Enterprise were worth $1,208,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also modified their holdings of AXON. ICA Group Wealth Management LLC acquired a new position in shares of Axon Enterprise in the 4th quarter valued at $26,000. Blue Trust Inc. lifted its stake in shares of Axon Enterprise by 987.5% in the 2nd quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock valued at $27,000 after purchasing an additional 79 shares during the last quarter. Trivant Custom Portfolio Group LLC purchased a new stake in shares of Axon Enterprise in the 1st quarter valued at $31,000. First PREMIER Bank purchased a new stake in shares of Axon Enterprise in the 1st quarter valued at $33,000. Finally, Rise Advisors LLC raised its holdings in shares of Axon Enterprise by 49.0% in the 1st quarter. Rise Advisors LLC now owns 143 shares of the biotechnology company’s stock valued at $45,000 after buying an additional 47 shares during the period. Institutional investors and hedge funds own 79.08% of the company’s stock.

Analyst Upgrades and Downgrades

AXON has been the topic of several research analyst reports. Craig Hallum boosted their price objective on Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a report on Wednesday, August 7th. Barclays boosted their price objective on Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a report on Wednesday, August 7th. Robert W. Baird boosted their price objective on Axon Enterprise from $360.00 to $400.00 and gave the company an “outperform” rating in a report on Tuesday, September 10th. Bank of America began coverage on Axon Enterprise in a report on Wednesday, July 17th. They issued a “buy” rating and a $380.00 price objective on the stock. Finally, Northland Securities upped their price target on Axon Enterprise from $330.00 to $365.00 and gave the stock an “outperform” rating in a report on Thursday, August 8th. Two investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat.com, Axon Enterprise has an average rating of “Moderate Buy” and a consensus price target of $365.38.

Insider Activity at Axon Enterprise

In related news, Director Matthew R. Mcbrady sold 2,000 shares of the company’s stock in a transaction dated Friday, August 9th. The stock was sold at an average price of $364.66, for a total value of $729,320.00. Following the completion of the sale, the director now directly owns 4,892 shares of the company’s stock, valued at approximately $1,783,916.72. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other Axon Enterprise news, CEO Patrick W. Smith sold 80,300 shares of the stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $371.78, for a total transaction of $29,853,934.00. Following the completion of the sale, the chief executive officer now directly owns 3,015,366 shares of the company’s stock, valued at approximately $1,121,052,771.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Matthew R. Mcbrady sold 2,000 shares of the stock in a transaction that occurred on Friday, August 9th. The stock was sold at an average price of $364.66, for a total value of $729,320.00. Following the sale, the director now directly owns 4,892 shares of the company’s stock, valued at $1,783,916.72. The disclosure for this sale can be found here. Insiders sold a total of 317,981 shares of company stock valued at $115,662,734 in the last three months. 6.10% of the stock is currently owned by company insiders.

Axon Enterprise Trading Down 0.8 %

AXON opened at $382.57 on Wednesday. Axon Enterprise, Inc. has a one year low of $189.12 and a one year high of $386.54. The company has a market cap of $28.87 billion, a P/E ratio of 111.86, a PEG ratio of 10.30 and a beta of 0.94. The company has a debt-to-equity ratio of 0.35, a quick ratio of 2.52 and a current ratio of 2.88. The business’s 50-day simple moving average is $340.58 and its 200-day simple moving average is $315.24.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings data on Tuesday, August 6th. The biotechnology company reported $1.20 EPS for the quarter, beating analysts’ consensus estimates of $1.02 by $0.18. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The business had revenue of $504.00 million for the quarter, compared to the consensus estimate of $478.35 million. During the same quarter in the prior year, the business posted $0.80 EPS. The business’s revenue for the quarter was up 34.5% on a year-over-year basis. As a group, equities research analysts expect that Axon Enterprise, Inc. will post 1.79 EPS for the current fiscal year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.